SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-005545
Filing Date
2024-02-27
Accepted
2024-02-27 17:10:22
Documents
1
Period of Report
2024-02-26

Document Format Files

Seq Description Document Type Size
1 form4-02272024_100213.html 4  
1 form4-02272024_100213.xml 4 7346
  Complete submission text file 0001415889-24-005545.txt   8785
Mailing Address C/O AMUNIX PHARMACEUTICALS, INC. 2 TOWER PLACE, #1100 SOUTH SAN FRANCISCO CA 94080
Business Address
You Angie (Reporting) CIK: 0001647664 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41799 | Film No.: 24688360

Mailing Address 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121 (619) 937-2754
RayzeBio, Inc. (Issuer) CIK: 0001825367 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)